News
-
Download Our Brochure
Learn how our consortium is working to develop innovative mRNA vaccines and immunotherapies against Crimean-Congo Hemorrhagic Fever (CCHF). Download the Brochure
-
CCHFVACIM Executive Committee Meeting on 2024, December 5th in Brussels
On 2024, December 5, the CCHFVACIM Executive Committee convened in Brussels at the Residence Palace for a morning of strategic discussions and updates. This pivotal meeting brought project partners together to review progress, address challenges, and outline priorities for the months ahead. Agenda Highlights Key Takeaways and Priorities Expected Impact Funded by Horizon Europe, CCHFVACIM aims to enhance preparedness against the Crimean-Congo Hemorrhagic Fever…
-
CCHFVACIM Kick-Off Meeting on 2024, March 19-20 in Paris
The CCHFVACIM Kick-Off Meeting aimed to establish the project’s foundational framework, ensuring effective collaboration among consortium members to advance research and innovation in combating Crimean-Congo hemorrhagic fever. The CCHFVACIM project will employ deep structural biology studies on viral glycoproteins, investigation of immunogenicity of viral antigens, and optimization of an mRNA vaccine candidate against CCHFV. Additionally,…
